Wal-Mart Aims for Marketshare in Health Care

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Wal-Mart Stores Inc. announced it will expand immunizations in more than 2,700 of its stores, a move analysts say will likely help the retailer grow its health care marketshare.

It’s no secret Wal-Mart continues to look for revenue opportunities and the health care sector is ripe for the picking. The retailer previously began offering a $4 generic drug program and Medicare prescription plan, which together comprised roughly 11% of the company’s $264 billion in U.S. sales last year, according to the Wall Street Journal.

“We are making it easy and affordable for our customers to receive their vaccinations – while on their normal shopping trips they can simply stop by immunization events, which will accept thousands of insurance plans and offer low price options for our cash paying customers,” said John Agwunobi, M.D., president of Walmart U.S. Health and Wellness.

A number of pharmacies both locally owned and national chains routinely give shots for shingles and the flu but Wal-Mart says it will be the first national retailer to have these shots administered to shoppers by registered nurses. Click here to read the full story from our partners at TheCityWire.com.